These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

746 related articles for article (PubMed ID: 37001541)

  • 1. Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study.
    Eyre DW; Futschik M; Tunkel S; Wei J; Cole-Hamilton J; Saquib R; Germanacos N; Dodgson AR; Klapper PE; Sudhanva M; Kenny C; Marks P; Blandford E; Hopkins S; Peto TEA; Fowler T
    Lancet Infect Dis; 2023 Aug; 23(8):922-932. PubMed ID: 37001541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.
    Pickering S; Batra R; Merrick B; Snell LB; Nebbia G; Douthwaite S; Reid F; Patel A; Kia Ik MT; Patel B; Charalampous T; Alcolea-Medina A; Lista MJ; Cliff PR; Cunningham E; Mullen J; Doores KJ; Edgeworth JD; Malim MH; Neil SJD; Galão RP
    Lancet Microbe; 2021 Sep; 2(9):e461-e471. PubMed ID: 34226893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid antigen testing for SARS-CoV-2 by lateral flow assay: A field evaluation of self- and professional testing at UK community testing sites.
    Futschik ME; Johnson S; Turek E; Chapman D; Carr S; Thorlu-Bangura Z; Klapper PE; Sudhanva M; Dodgson A; Cole-Hamilton JR; Germanacos N; Kulasegaran-Shylini R; Blandford E; Tunkel S; Peto T; Hopkins S; Fowler T
    J Clin Virol; 2024 Apr; 171():105654. PubMed ID: 38387136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing.
    Peto T;
    EClinicalMedicine; 2021 Jun; 36():100924. PubMed ID: 34101770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial.
    Love NK; Ready DR; Turner C; Verlander NQ; French CE; Martin AF; Sorensen TB; Metelmann S; Denford S; Rubin GJ; Yardley L; Amlôt R; Hopkins S; Oliver I
    Lancet Respir Med; 2022 Nov; 10(11):1074-1085. PubMed ID: 36228640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 rapid antigen test sensitivity and viral load in newly symptomatic hospital employees in Berlin, Germany, December, 2020 to February, 2022: an observational study.
    Meiners L; Horn J; Jones TC; Mühlemann B; Schmidt ML; Walper F; Menzel P; Schwarzer R; Rose R; Krumbholz A; Corman VM; Seybold J; Drosten C
    Lancet Microbe; 2024 Jun; 5(6):e538-e546. PubMed ID: 38759669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity by Viral Load, S Gene Variants and Demographic Factors, and the Utility of Lateral Flow Devices to Prevent Transmission.
    Lee LYW; Rozmanowski S; Pang M; Charlett A; Anderson C; Hughes GJ; Barnard M; Peto L; Vipond R; Sienkiewicz A; Hopkins S; Bell J; Crook DW; Gent N; Walker AS; Peto TEA; Eyre DW
    Clin Infect Dis; 2022 Feb; 74(3):407-415. PubMed ID: 33972994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of the sensitivity and specificity of lateral flow devices in the detection of SARS-CoV-2.
    Mistry DA; Wang JY; Moeser ME; Starkey T; Lee LYW
    BMC Infect Dis; 2021 Aug; 21(1):828. PubMed ID: 34407759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021.
    Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit J; Xavier Gómez-Olivé F; Dawood FS; Mkhencele T; Sun K; Viboud C; ; Tempia S
    medRxiv; 2021 Dec; ():. PubMed ID: 34909794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study.
    Hakki S; Zhou J; Jonnerby J; Singanayagam A; Barnett JL; Madon KJ; Koycheva A; Kelly C; Houston H; Nevin S; Fenn J; Kundu R; Crone MA; Pillay TD; Ahmad S; Derqui-Fernandez N; Conibear E; Freemont PS; Taylor GP; Ferguson N; Zambon M; Barclay WS; Dunning J; Lalvani A;
    Lancet Respir Med; 2022 Nov; 10(11):1061-1073. PubMed ID: 35988572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.
    Singanayagam A; Hakki S; Dunning J; Madon KJ; Crone MA; Koycheva A; Derqui-Fernandez N; Barnett JL; Whitfield MG; Varro R; Charlett A; Kundu R; Fenn J; Cutajar J; Quinn V; Conibear E; Barclay W; Freemont PS; Taylor GP; Ahmad S; Zambon M; Ferguson NM; Lalvani A;
    Lancet Infect Dis; 2022 Feb; 22(2):183-195. PubMed ID: 34756186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Rapid Antigen Tests' Performance Between Delta and Omicron Variants of SARS-CoV-2 : A Secondary Analysis From a Serial Home Self-testing Study.
    Soni A; Herbert C; Filippaios A; Broach J; Colubri A; Fahey N; Woods K; Nanavati J; Wright C; Orwig T; Gilliam K; Kheterpal V; Suvarna T; Nowak C; Schrader S; Lin H; O'Connor L; Pretz C; Ayturk D; Orvek E; Flahive J; Lazar P; Shi Q; Achenbach C; Murphy R; Robinson M; Gibson L; Stamegna P; Hafer N; Luzuriaga K; Barton B; Heetderks W; Manabe YC; McManus D
    Ann Intern Med; 2022 Dec; 175(12):1685-1692. PubMed ID: 36215709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing lateral flow testing with a rapid RT-PCR method for SARS-CoV-2 detection in the United Kingdom-A retrospective diagnostic accuracy study.
    Taylor A; Calvez R; Atkins M; Fink CG
    Health Sci Rep; 2022 Sep; 5(5):e811. PubMed ID: 36177402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acceptability of testing contacts of confirmed COVID-19 cases using serial, self-administered lateral flow devices as an alternative to self-isolation.
    Love NK; Ready DR; Turner C; Yardley L; Rubin GJ; Hopkins S; Oliver I
    J Med Microbiol; 2022 Aug; 71(8):. PubMed ID: 35947525
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study.
    Gibani MM; Toumazou C; Sohbati M; Sahoo R; Karvela M; Hon TK; De Mateo S; Burdett A; Leung KYF; Barnett J; Orbeladze A; Luan S; Pournias S; Sun J; Flower B; Bedzo-Nutakor J; Amran M; Quinlan R; Skolimowska K; Herrera C; Rowan A; Badhan A; Klaber R; Davies G; Muir D; Randell P; Crook D; Taylor GP; Barclay W; Mughal N; Moore LSP; Jeffery K; Cooke GS
    Lancet Microbe; 2020 Nov; 1(7):e300-e307. PubMed ID: 32964211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of 2 Rapid Antigen Tests During 3 Phases of SARS-CoV-2 Variants.
    Drain PK; Bemer M; Morton JF; Dalmat R; Abdille H; Thomas KK; Uppal TK; Hau D; Green HR; Gates-Hollingsworth MA; AuCoin DP; Verma SC
    JAMA Netw Open; 2022 Aug; 5(8):e2228143. PubMed ID: 36001317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of rapid antigen tests (RAT) for COVID-19 and factors associated with RAT-negative results among RT-PCR-positive individuals during Omicron BA.2, BA.5 and XBB.1 predominance.
    Tan CY; Zeng K; Cui L; Lin RTP; Chen M
    BMC Infect Dis; 2024 May; 24(1):504. PubMed ID: 38769524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.